South Korea

South Korean hospital acquires advanced radiation cancer treatment devices

The equipment can precisely treat tumour-target tissue whilst minimising radiation exposure.

Catholic Medical Center trailblazing big data and AI adoption in Korean healthcare

Its flagship Seoul St. Mary’s Hospital leads the seamless integration of cutting-edge technology across CMC’s eight affiliate hospitals.

Korean hospital to develop digital recovery room for breast cancer patients

The recovery room seeks to use mobile and web-based AI to monitor recovery status.

Seoul National University Bundang Hospital garners GHA second accreditation

It earned the accreditation with its tech and smart healthcare environment.

Samsung Medical launches blood-based colorectal cancer screening test in South Korea

Colorectal cancer is the third-leading cause of cancer-related deaths in South Korea.

South Korea nominated as member of WHO’s executive board

It was voted as one of the two WHO executive board members which begins May 2024.

Korean gov’t launches Bio-Health Innovation Commission to support AI and nanotech growth

This will address the challenges of fragmented government policies in bio-health tasks.

South Korea opens first theranostics center

Asan Medical Center leads the expansion and research of cancer-treating radiopharmaceuticals.

South Korea revises healthcare data standards for interoperability

It will promote interoperability of data in its healthcare systems.

South Korea selects five regions to host bio training campuses for foreign workers

Foreign workers will be trained to produce biologicals like vaccines and therapeutics within the campuses.

KHIDI’s Medical Charity Programme wins ESG Programme of the Year

South Korea has supported patients from 28 different countries with little access to healthcare services.

German pharmaceutical firm plans new APAC bioprocessing plant in South Korea

Merck will use its Asia Pacific Bioprocessing Center for commercial manufacturing for its biotech and pharmaceutical clients.

South Korea neurology devices market to grow by 4% through 2030

Researchers developed a new paradigm in neurodegenerative diseases treatment.

South Korea stays attractive to pharma sector despite drug approval lag

High spending and an innovative R&D environment are expected to ensure attractiveness.

South Korea urged to revise cancer tests reimbursement system

The timeline to set the cost is currently longer than that of the reimbursement decision.

South Korean hospitals in need of AI transformation to improve diagnostics

The diagnostic imaging market is seen to grow at 5% between 2023 and 2030.